These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 35126105)

  • 1. Evolution of a Paradigm Switch in Diagnosis and Treatment of HPV-Driven Head and Neck Cancer-Striking the Balance Between Toxicity and Cure.
    Tawk B; Debus J; Abdollahi A
    Front Pharmacol; 2021; 12():753387. PubMed ID: 35126105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinico-pathological peculiarities of human papilloma virus driven head and neck squamous cell carcinoma: A comprehensive update.
    Devaraja K; Aggarwal S; Verma SS; Gupta SC
    Life Sci; 2020 Mar; 245():117383. PubMed ID: 32007572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of local p16 testing for determination of human papilloma virus status eligibility on a low risk oropharyngeal cancer trial - A Trans-Tasman Radiation Oncology Group study.
    Young RJ; Solomon B; Corry J; Angel C; Kenny L; Porceddu S; Wratten C; Macann A; Jackson JE; Herschtal A; Rischin D
    Oral Oncol; 2020 Nov; 110():104988. PubMed ID: 32889172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives.
    Rosenberg AJ; Vokes EE
    Oncologist; 2021 Jan; 26(1):40-48. PubMed ID: 32864799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Papillomavirus DNA Detection by Droplet Digital PCR in Formalin-Fixed Paraffin-Embedded Tumor Tissue from Oropharyngeal Squamous Cell Carcinoma Patients.
    Schiavetto CM; de Abreu PM; von Zeidler SV; de Jesus LM; Carvalho RS; Cirino MT; Carloni AC; Oliveira C; Scapulatempo-Neto C; de Almeida GC; de Menezes NS; Carvalho AL; Reis RM; de Carvalho AC
    Mol Diagn Ther; 2021 Jan; 25(1):59-70. PubMed ID: 33245553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine-needle aspiration of cervical lymph nodes yields adequate materials for accurate HPV testing in metastatic head and neck squamous cell carcinomas.
    Hou Y; Chaudhary S; Shen R; Li Z
    Diagn Cytopathol; 2016 Oct; 44(10):792-8. PubMed ID: 27465660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.
    Arsa L; Siripoon T; Trachu N; Foyhirun S; Pangpunyakulchai D; Sanpapant S; Jinawath N; Pattaranutaporn P; Jinawath A; Ngamphaiboon N
    BMC Cancer; 2021 May; 21(1):504. PubMed ID: 33957888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers-HPV and Beyond.
    Rühle A; Grosu AL; Nicolay NH
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34064321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
    Wong KS; Krane JF; Jo VY
    Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of TORS as De-Escalation Strategy in HPV-Related Oropharyngeal Cancer, What We Need to Know.
    Molteni G; Bassani S; Arsie AE; Zampieri E; Mannelli G; Orlandi E; Bossi P; De Virgilio A
    Healthcare (Basel); 2024 May; 12(10):. PubMed ID: 38786424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of Cervista Human Papillomavirus 16/18 Assay Into Algorithms for Classifying Human Papillomavirus Status in Formalin-Fixed, Paraffin-Embedded Head and Neck Squamous Carcinoma Specimens.
    Guo M; Khanna A; Wang J; Williams MD; Kalhor N; Gong Y; Xu L; Sturgis EM; Staerkel G
    Arch Pathol Lab Med; 2019 Mar; 143(3):356-361. PubMed ID: 30221979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC.
    Linge A; Schötz U; Löck S; Lohaus F; von Neubeck C; Gudziol V; Nowak A; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Bunea H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Lauber K; Pigorsch S; Combs SE; Mönnich D; Zips D; Baretton GB; Buchholz F; Krause M; Belka C; Baumann M;
    Radiother Oncol; 2018 Apr; 127(1):27-35. PubMed ID: 29295747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV Status as Prognostic Biomarker in Head and Neck Cancer-Which Method Fits the Best for Outcome Prediction?
    Kühn JP; Schmid W; Körner S; Bochen F; Wemmert S; Rimbach H; Smola S; Radosa JC; Wagner M; Morris LGT; Bozzato V; Bozzato A; Schick B; Linxweiler M
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De-intensification strategies in HPV-related oropharyngeal squamous cell carcinoma-a narrative review.
    Strohl MP; Wai KC; Ha PK
    Ann Transl Med; 2020 Dec; 8(23):1601. PubMed ID: 33437800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Diagnostic Utility of a High-Risk Human Papillomavirus PCR Test on Formalin-Fixed, Paraffin-Embedded Head and Neck Tumor Tissues.
    Huho AN; Yadak N; Bocklage TJ; Yang S
    J Mol Diagn; 2018 Mar; 20(2):232-239. PubMed ID: 29277636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.
    Maqsood S; Jameson MB; De Groot C; Hartopeanu C; Yasin NABHM; Thotathil Z
    Cancer Rep (Hoboken); 2018 Jun; 1(1):e1001. PubMed ID: 32729235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of tumor surface brushings to detect human papilloma virus DNA in head and neck cancer.
    Kofler B; Borena W; Manzl C; Dudas J; Wegscheider AS; Jansen-Dürr P; Schartinger V; Riechelmann H
    Oral Oncol; 2017 Apr; 67():103-108. PubMed ID: 28351563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DAHANCA 28: A phase I/II feasibility study of hyperfractionated, accelerated radiotherapy with concomitant cisplatin and nimorazole (HART-CN) for patients with locally advanced, HPV/p16-negative squamous cell carcinoma of the oropharynx, hypopharynx, larynx and oral cavity.
    Saksø M; Jensen K; Andersen M; Hansen CR; Eriksen JG; Overgaard J
    Radiother Oncol; 2020 Jul; 148():65-72. PubMed ID: 32335364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of p16 as a surrogate marker for transcriptionally active human papillomavirus status of oropharyngeal squamous cell carcinoma in an eastern Chinese population.
    Xu S; Sun B; Zhou R; Shi C; Han Y; Li J; Sun J; Tian Z; Zhang Z; Li J
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):236-245.e2. PubMed ID: 31987673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated RNA In Situ Hybridization for 18 High Risk Human Papilloma Viruses in Squamous Cell Carcinoma of the Head and Neck: Comparison With p16 Immunohistochemistry.
    Drumheller B; Cohen C; Lawson D; Siddiqui MT
    Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):160-164. PubMed ID: 28777152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.